Health Ministry reviews progress, highlights targeted interventions in high-burden states, and calls for stronger surveillance and stigma reduction to achieve a leprosy-free India
Despite the disruption, the company stressed that “our core business operations are not impacted and remain up and running.
MeRT becomes one of the few FDA-cleared neuromodulation therapies for PTSD, using EEG biomarkers and AI to personalize treatment for patients with treatment-resistant symptoms
SENS study to assess feasibility, effectiveness and family experience of introducing SMA screening into the NHS newborn screening programme
KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation
Recognition highlights the hospital network’s decade-long investment in analytics and AI-driven healthcare, supporting improved outcomes, efficiency, and affordability.
Enhanced CMC infrastructure at Cranbury site aims to improve bioavailability, streamline formulation development and support faster progression of challenging drug candidates into clinical trials
Digital platform aims to expand access to palliative care through teleconsultations, training, community engagement and global knowledge-sharing
Collaboration aims to accelerate medicinal chemistry decision-making, reduce synthesis burden and strengthen data-secure AI adoption in drug discovery
Approval expands treatment options for patients with unresectable or metastatic HER2-positive breast cancer
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
